← Open Payments lookup

JENNIFER SHERWOOD: Open Payments

NPI 1710429394 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$118 in 6 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $18 · 2025 $118

Food & beverage: $118
CompanyPaymentsAmount
ABBVIE INC.2$34
Neurocrine BioSciences, Inc.1$32
Supernus Pharmaceuticals, Inc.1$19
Lundbeck LLC1$18
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: VRAYLAR, INGREZZA, Qelbree, REXULTI, TRINTELLIX.

Industry payments across MD — which companies pay providers there.